WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2006122914) MEDICAMENT, PARTICULARLY AN ANTI-CANCER MEDICAMENT, FOR TREATMENT USING IMMUNOTHERAPY, PARTICULARLY AUTOLOGOUS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2006/122914    International Application No.:    PCT/EP2006/062296
Publication Date: 23.11.2006 International Filing Date: 15.05.2006
Chapter 2 Demand Filed:    13.03.2007    
IPC:
A61K 9/00 (2006.01), A61K 9/18 (2006.01), A61P 35/00 (2006.01)
Applicants: URODELIA [FR/FR]; Lieu dit "Le Gaillard", Route de Saint Thomas, F-31470 Saint Lys (FR) (For All Designated States Except US).
CIOCCA, Daniel [AR/AR]; (AR).
FRAYSSINET, Patrick [FR/FR]; (FR) (For US Only).
ROUQUET, Nicole [FR/FR]; (FR) (For US Only)
Inventors: CIOCCA, Daniel; (AR).
FRAYSSINET, Patrick; (FR).
ROUQUET, Nicole; (FR)
Agent: CABINET PLASSERAUD; 52, rue de la Victoire, F-75440 Paris Cedex 09 (FR)
Priority Data:
05/51262 13.05.2005 FR
Title (EN) MEDICAMENT, PARTICULARLY AN ANTI-CANCER MEDICAMENT, FOR TREATMENT USING IMMUNOTHERAPY, PARTICULARLY AUTOLOGOUS
(FR) MEDICAMENT NOTAMMENT ANTI-CANCEREUX, DESTINE A DES TRAITEMENTS PAR IMMUNOTHERAPIE, EN PARTICULIER AUTOLOGUE
Abstract: front page image
(EN)The invention relates to a medicament characterized in that it comprises at least one solid biocompatible support, preferably in powder form, on which at least one active substance, preferably selected among biological materials and/or biological molecules, is adsorbed or on which it is to be adsorbed, preferably without requiring a coupling agent. Said solid biocompatible support is capable of purifying the active substance. The invention relates to also relates to a method for preparing a medicament of the aforementioned type, this method essentially consisting of placing at least one solid biocompatible support, preferably in powder form, in contact with at least one active substance, preferably selected among biological materials and/or biological molecules, in such a manner that the active substance is reversibly adsorbed and without denaturing on the support.
(FR)La présente invention concerne un médicament caractérisé en ce qu'il comprend au moins un support solide biocompatible, de préférence en poudre, sur lequel est adsorbée ou sur lequel est destinée à être adsorbée, de préférence sans nécessiter d'agent couplant, au moins une substance active, de préférence choisie parmi les matériaux biologiques et/ou les molécules biologiques, ledit support solide biocompatible étant apte à purifier ladite substance active. L'invention concerne également un procédé de préparation d'un tel médicament, procédé qui consiste essentiellement à mettre en contact au moins un support solide biocompatible, de préférence en poudre, avec au moins une substance active, de préférence choisie parmi les matériaux biologiques et/ou les molécules biologiques, de manière à ce que la substance active s'adsorbe réversiblement et sans dénaturation sur le support.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: French (FR)
Filing Language: French (FR)